Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TNDM |
---|---|---|
09:32 ET | 22379 | 40.16 |
09:34 ET | 3323 | 40.4 |
09:36 ET | 6107 | 40.07 |
09:38 ET | 1381 | 40.12 |
09:39 ET | 4111 | 40.545 |
09:41 ET | 1086 | 40.81 |
09:43 ET | 2433 | 40.83 |
09:45 ET | 2500 | 40.61 |
09:48 ET | 5412 | 40.47 |
09:50 ET | 3927 | 40.52 |
09:52 ET | 8477 | 40.5 |
09:54 ET | 3667 | 40.675 |
09:56 ET | 3248 | 40.58 |
09:57 ET | 7196 | 40.55 |
09:59 ET | 500 | 40.59 |
10:01 ET | 8857 | 40.425 |
10:03 ET | 2907 | 40.11 |
10:06 ET | 4841 | 40.08 |
10:08 ET | 1335 | 39.89 |
10:10 ET | 6661 | 39.94 |
10:12 ET | 3420 | 39.9 |
10:14 ET | 2900 | 39.76 |
10:15 ET | 4801 | 39.58 |
10:17 ET | 2236 | 39.565 |
10:19 ET | 16660 | 39.8 |
10:21 ET | 2111 | 39.8 |
10:24 ET | 1599 | 39.9175 |
10:26 ET | 2812 | 40.09 |
10:28 ET | 9603 | 40.0568 |
10:30 ET | 700 | 40.01 |
10:32 ET | 15055 | 39.85 |
10:33 ET | 4710 | 39.715 |
10:35 ET | 4100 | 39.83 |
10:37 ET | 1000 | 39.83 |
10:39 ET | 3934 | 39.68 |
10:42 ET | 2474 | 39.63 |
10:44 ET | 4988 | 39.59 |
10:46 ET | 5129 | 39.495 |
10:48 ET | 2302 | 39.475 |
10:50 ET | 2900 | 39.5 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Tandem Diabetes Care Inc | 2.6B | -18.2x | --- |
Myriad Genetics Inc | 2.2B | -8.6x | --- |
10X Genomics Inc | 2.3B | -8.5x | --- |
Inari Medical Inc | 2.8B | -121.1x | --- |
STAAR Surgical Co | 2.3B | 155.0x | +31.52% |
LivaNova PLC | 3.0B | -93.4x | --- |
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.6B |
---|---|
Revenue (TTM) | $770.0M |
Shares Outstanding | 64.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.28 |
EPS | $-2.17 |
Book Value | $4.78 |
P/E Ratio | -18.2x |
Price/Sales (TTM) | 3.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -19.27% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.